CAI Caris Life Sciences, Inc.
CAI Caris Life Sciences, Inc.
Healthcare · Biotechnology
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 bull converging
POC $16.22 · VWAP $22.58 · +35.3% vs 12m avg buyer
Insiders selling 0 buy / 2 sell · Form 4, 90d $27M sold last open-market sell Brille Brian J
Cluster 2 reporting owners sold $12.4M, Sep 17–23
Coverage
1 watchlist
CAI Price Structure
Loading timeframes…
Peers
Every watchlist CAI belongs to, members best 30-day change first — CAI highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Against street estimates
How CAI's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
CAI research tape
31 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.